A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).

出版年份 2017 全文链接

标题

作者

关键词

出版物

Volume 28, Issue 15_suppl, Pages 7054-7054

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2017-02-24

DOI

10.1200/jco.2010.28.15_suppl.7054

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started